« previous next »
Pages: [1]

Author Topic: (Abst.) Mechanism-based criteria to improve therapeutic outcomes in progressive MS  (Read 20 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Mechanism-based criteria to improve therapeutic outcomes in progressive MS
« on: November 06, 2021, 09:09:17 pm »
From PubMed (November 5, 2021)--"Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/34732831/


Note: Spingosine 1-phosphate receptor modulators for MS = fingolimod, ponesimod, ozanimod, siponimod
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
157 Views 		Last post August 02, 2016, 03:49:50 pm
by agate
0 Replies
84 Views 		Last post August 18, 2016, 04:28:15 pm
by agate
0 Replies
116 Views 		Last post November 02, 2018, 07:30:04 am
by agate
1 Replies
120 Views 		Last post March 04, 2019, 09:36:37 pm
by agate
0 Replies
95 Views 		Last post July 11, 2019, 09:17:54 am
by agate